Apollomics Inc.
APLM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $223.8K in total; no superinvestor holds it.
Other share classesAPLMW
Q1 2025 vs. Q4 2024
How the institutions holding Apollomics Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 5 | 4 | −1 |
| Shares | 12.8K | 2.41K | −10.4K (−81.2%) |
| Value | $129.0K | $14.9K | −$114.1K (−88.4%) |
New holders (1)
Institutions that held Apollomics Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Harbour Investments, Inc. | 50 | $310 | 0.00% |
Sold out (2)
Institutions that held Apollomics Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Exchange Traded Concepts, LLC | 12,592 | $126.8K |
| Tower Research Capital LLC (TRC) | 37 | $361 |